Pfizer trial data: Hospitalization MORE likely with COVID shot
An analysis of Pfizer and Moderna COVID vaccine trials found the mRNA shots are more likely to land a recipient in the hospital than to provide protection from a severe adverse event.
In a pre-print study, meaning the paper has not yet been peer-reviewed, British Medical Journal Editor Dr. Peter Doshi and several other medical scientists looked for serious adverse events, as defined by the trial protocols, the U.K. website Daily Sceptic reported.
The adverse events they focused on were based on the World Health Organization's list of events of special interest: death; life-threatening at the time of the event; inpatient hospitalization or prolongation of existing hospitalization; persistent or significant disability/incapacity; a congenital anomaly/birth defect; medically important event, based on medical judgment."
Read more here: https://www.wnd.com/2022/0...